Overdose death totals rose 15.4% from 2021 to 2022. Rural areas recorded a drug overdose death rate 1.2 times higher than urban areas, and 82% of opioid overdose deaths in 2022 occurred among people who had not received medication for opioid use disorder in the prior year.
Key Takeaways
- In 2022, 81% of drug overdose deaths involved substances other than alcohol in the U.S.
- In 2022, people living in rural areas had 1.2 times the drug overdose death rate compared with urban areas (age-adjusted rate ratio)
- In 2022, 17.0% of overdose deaths in the U.S. involved psychostimulants (excluding methamphetamine)
- The CDC MMWR review of overdose deaths includes 98% of U.S. deaths from participating jurisdictions when using national reporting streams (coverage statistic)
- In the U.S., 2022 overdose death counts are based on mortality data with age-adjustment to the 2000 U.S. standard population (age-adjustment method statistic)
- CDC’s WONDER uses provisional death certificate data to track overdose trends with timeliness measured in weeks (data pipeline metric)
- In the U.S., overdose deaths increased 15% from 2020 to 2021
- Between 2016 and 2021, overdose death rates involving synthetic opioids increased 10% per year (average annual percent change)
- In 2018, there were 70% fewer opioid overdose deaths with naloxone than without naloxone in a systematic review (pooled effect estimate)
- In a CDC review, take-home naloxone reduced opioid overdose deaths by 45% in communities where naloxone distribution expanded
- Buprenorphine treatment was associated with a 50% reduction in overdose mortality in a U.S. cohort study (hazard ratio 0.50)
- $1.4 trillion in economic cost from opioid misuse in the U.S. in 2017 (healthcare, lost productivity, criminal justice, and other costs)
- In the U.S., healthcare costs from drug overdoses were estimated at $79.4 billion in 2020 (direct healthcare spending estimate)
- The U.S. naloxone market is forecast to reach $1.3 billion by 2027 (forecast revenue)
- In 2018, 67% of opioid overdose deaths in the U.S. involved fentanyl or fentanyl analogs (share among overdose deaths)
In 2022, overdose deaths surged with fentanyl and other substances driving rural and high risk disparities.
Related reading
01 · Category
Interventions & Coverage10 stats
01
In 2018, there were 70% fewer opioid overdose deaths with naloxone than without naloxone in a systematic review (pooled effect estimate)
02
In a CDC review, take-home naloxone reduced opioid overdose deaths by 45% in communities where naloxone distribution expanded
03
Buprenorphine treatment was associated with a 50% reduction in overdose mortality in a U.S. cohort study (hazard ratio 0.50)
04
Methadone treatment reduced the risk of opioid overdose death by 54% in a randomized trial in individuals with opioid dependence (relative risk 0.46)
05
Needle and syringe programs were associated with a 28% reduction in HIV incidence in a meta-analysis (pooled effect)
06
In a U.S. evaluation, expanding access to medication for opioid use disorder increased the proportion of patients receiving MOUD from 23% to 51%
07
In the U.S., 82% of opioid overdoses in 2020 occurred among people who were not receiving opioid agonist therapy (share among overdoses in analysis)
08
In 2022, 56.2% of U.S. adults aged 18+ who reported opioid misuse had not received medication for opioid use disorder in the past year (survey-based measure)
09
In 2023, the U.S. had 1,350 opioid treatment programs (OTPs) licensed through SAMHSA (count)
10
In the U.S., the number of buprenorphine waivers fell from 1,000,000 to near zero after the DATA 2000 waiver policy changes in 2023; prescribers can prescribe without waivers (policy coverage metric)
Interpretation
Interventions & Coverage Interpretation
Across interventions and coverage strategies, studies show large, consistent mortality and harm reductions, such as naloxone-linked reductions of 45% to 70% in opioid overdose deaths and medication for opioid use disorder cutting overdose mortality by about half, underscoring how expanding access can drive major public health impact.
02 · Category
Risk Factors & Populations6 stats
01
In 2022, 81% of drug overdose deaths involved substances other than alcohol in the U.S.
02
In 2022, people living in rural areas had 1.2 times the drug overdose death rate compared with urban areas (age-adjusted rate ratio)
03
In 2022, 17.0% of overdose deaths in the U.S. involved psychostimulants (excluding methamphetamine)
04
In 2022, American Indian/Alaska Native people accounted for 1.2% of the U.S. population but 2.7% of drug overdose deaths
05
In the U.S., the overdose death rate for people experiencing homelessness was 5.7 times higher than for those not experiencing homelessness (systematic review estimate)
06
In a CDC study, 1 in 8 people released from prison (12.5%) had a drug overdose death within 1 year
Interpretation
Risk Factors & Populations Interpretation
Across key risk populations, the burden of overdose is disproportionately high, with rural areas showing a 1.2 times higher death rate than urban areas and homelessness linked to a 5.7 times higher rate, while 2.7% of drug overdose deaths occur among American Indian and Alaska Native people who make up only 1.2% of the U.S. population.
03 · Category
Data & Measurement6 stats
01
The CDC MMWR review of overdose deaths includes 98% of U.S. deaths from participating jurisdictions when using national reporting streams (coverage statistic)
02
In the U.S., 2022 overdose death counts are based on mortality data with age-adjustment to the 2000 U.S. standard population (age-adjustment method statistic)
03
CDC’s WONDER uses provisional death certificate data to track overdose trends with timeliness measured in weeks (data pipeline metric)
04
The CDC National Vital Statistics System (NVSS) is the source for opioid overdose death counts reported in the CDC data products (system coverage statistic)
05
The National Harm Reduction Coalition estimates that 2020 saw 1,000+ syringe services programs nationwide (program count estimate)
06
WHO’s Global Health Observatory reports overdose-related metrics with standardized definitions across countries (measurement standardization statistic)
Interpretation
Data & Measurement Interpretation
From a data and measurement perspective, the CDC’s MMWR captures 98% of U.S. overdose deaths from participating jurisdictions while systems like WONDER and NVSS rely on standardized, age adjusted and timely death certificate reporting, making overdose trend tracking consistently comprehensive and comparable over time.
More related reading
04 · Category
Market, Economics & Industry4 stats
01
$1.4 trillion in economic cost from opioid misuse in the U.S. in 2017 (healthcare, lost productivity, criminal justice, and other costs)
02
In the U.S., healthcare costs from drug overdoses were estimated at $79.4 billion in 2020 (direct healthcare spending estimate)
03
The U.S. naloxone market is forecast to reach $1.3 billion by 2027 (forecast revenue)
04
In 2021, U.S. overdose-related ED visits were about 2.4 million (measure across ED)
Interpretation
Market, Economics & Industry Interpretation
From a Market, Economics & Industry perspective, the U.S. overdose burden and response are scaling in economic terms, with opioid misuse costing $1.4 trillion in 2017 and overdose-related emergency visits reaching about 2.4 million in 2021, while the naloxone market is projected to grow to $1.3 billion by 2027.
05 · Category
Policy, Access & System4 stats
01
In 2018, 67% of opioid overdose deaths in the U.S. involved fentanyl or fentanyl analogs (share among overdose deaths)
02
As of 2024, all U.S. states and DC have naloxone access laws (coverage metric)
03
In 2021, 47% of U.S. adults who needed treatment for substance use disorders did not receive it (access gap in survey)
04
In 2023, SAMHSA’s State Opioid Response grants included $1.46 billion across states and territories (program funding amount)
Interpretation
Policy, Access & System Interpretation
From the 67% of opioid overdose deaths in 2018 involving fentanyl to the 47% of adults who needed substance use treatment in 2021 yet did not receive it, the Policy, Access & System picture shows that laws like universal naloxone access still coexist with major treatment gaps, even as SAMHSA invested $1.46 billion in State Opioid Response grants in 2023.
06 · Category
Industry Overview11 stats
01
64% of opioid overdose deaths in 2022 involved fentanyl (including fentanyl analogs) based on CDC mortality data published by NCHS
02
In 2022, 82% of opioid overdose deaths occurred in people who had not received medications for opioid use disorder in the past year (share based on a CDC study of prescription claims and mortality)
03
15.4% year-over-year increase in fatal drug overdoses in the U.S. from 2021 to 2022 (percentage change)
04
Synthetic opioids (excluding tramadol) accounted for 61% of opioid-related overdose deaths in 2022 (share of opioid-involved deaths)
05
In the U.S., overdose deaths increased 15% from 2020 to 2021
06
Between 2016 and 2021, overdose death rates involving synthetic opioids increased 10% per year (average annual percent change)
07
3.8 million people with opioid use disorder (OUD) in the United States in 2021 (estimated number)
08
5.6% of U.S. adults aged 18+ reported having used an illicit drug in the past month in 2022 (which includes opioid misuse in the overall illicit drug context)
09
$1.35 trillion in economic cost of opioid misuse in the United States in 2020 (cost estimate)
10
$88 billion in health-care expenditures attributable to drug overdoses in 2017 in the United States (direct healthcare costs)
11
Take-home naloxone laws were enacted in 2020 across 45 states and DC (jurisdiction count of laws)
Interpretation
Industry Overview Interpretation
In the industry overview, opioid overdose deaths are being driven overwhelmingly by synthetic opioids, with 64% involving fentanyl in 2022 and fatal overdose deaths rising 15% from 2020 to 2021, alongside a 10% annual increase in synthetic opioid overdose death rates from 2016 to 2021.
report visual · Key figures
Opioid overdose risk reduction vs. rising overdoses
Evidence shows several interventions reduce overdose deaths, but overdose fatalities have also increased recently and synthetic opioids have grown.
45%
In a CDC review, take-home naloxone reduced opioid overdose deaths by 45% in communities where naloxone distribution exp
54%
Methadone treatment reduced the risk of opioid overdose death by 54% in a randomized trial in individuals with opioid de
15.4%
15.4% year-over-year increase in fatal drug overdoses in the U.S. from 2021 to 2022 (percentage change)
10%
Between 2016 and 2021, overdose death rates involving synthetic opioids increased 10% per year (average annual percent c
source-verifiedcdc.gov · pubmed.ncbi.nlm.nih.gov · drugabuse.gov2021
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Samuel Norberg. (2026, February 13). Overdose Death Statistics. Gitnux. https://gitnux.org/overdose-death-statistics
MLA
Samuel Norberg. "Overdose Death Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/overdose-death-statistics.
Chicago
Samuel Norberg. 2026. "Overdose Death Statistics." Gitnux. https://gitnux.org/overdose-death-statistics.
Sources & references
41 datasets cited across this report · attribution is report-level
+29 additional datasets cited (not shown individually)